Literature DB >> 11090189

Varicella-zoster virus gene expression in latently infected and explanted human ganglia.

P G Kennedy1, E Grinfeld, J E Bell.   

Abstract

A consistent feature of varicella-zoster virus (VZV) latency is the restricted pattern of viral gene expression in human ganglionic tissues. To understand further the significance of this gene restriction, we used in situ hybridization (ISH) to detect the frequency of RNA expression for nine VZV genes in trigeminal ganglia (TG) from 35 human subjects, including 18 who were human immunodeficiency virus (HIV) positive. RNA for VZV gene 21 was detected in 7 of 11 normal and 6 of 10 HIV-positive subjects, RNA for gene 29 was detected in 5 of 14 normal and 11 of 11 HIV-positive subjects, RNA for gene 62 was detected in 4 of 10 normal and 6 of 9 HIV-positive subjects, and RNA for gene 63 was detected in 8 of 17 normal and 12 of 15 HIV-positive subjects. RNA for VZV gene 4 was detected in 2 of 13 normal and 4 of 9 HIV-positive subjects, and RNA for gene 18 was detected in 4 of 15 normal and 5 of 15 HIV-positive subjects. By contrast, RNAs for VZV genes 28, 40, and 61 were rarely or never detected. In addition, immunocytochemical analysis detected the presence of VZV gene 63-encoded protein in five normal and four HIV-positive subjects. VZV RNA was also analyzed in explanted fresh human TG and dorsal root ganglia from five normal human subjects over a period of up to 11 days in culture. We found a very different pattern of gene expression in these explants, with transcripts for VZV genes 18, 28, 29, 40, and 63 all frequently detected, presumably as a result of viral reactivation. Taken together, these data provide further support for the notion of significant and restricted viral gene expression in VZV latency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090189      PMCID: PMC112472          DOI: 10.1128/jvi.74.24.11893-11898.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

Review 1.  The problems of latent varicella zoster virus in human ganglia: precise cell location and viral content.

Authors:  R Mahalingam; P G Kennedy; D H Gilden
Journal:  J Neurovirol       Date:  1999-10       Impact factor: 2.643

Review 2.  Neurologic complications of the reactivation of varicella-zoster virus.

Authors:  D H Gilden; B K Kleinschmidt-DeMasters; J J LaGuardia; R Mahalingam; R J Cohrs
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

3.  Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia.

Authors:  D H Gilden; Y Rozenman; R Murray; M Devlin; A Vafai
Journal:  Ann Neurol       Date:  1987-09       Impact factor: 10.422

4.  Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA.

Authors:  R J Cohrs; M Barbour; D H Gilden
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  Latent Varicella-zoster virus in human dorsal root ganglia.

Authors:  P G Kennedy; E Grinfeld; J W Gow
Journal:  Virology       Date:  1999-06-05       Impact factor: 3.616

6.  Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells.

Authors:  J J LaGuardia; R J Cohrs; D H Gilden
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia.

Authors:  P G Kennedy; E Grinfeld; J W Gow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

8.  Reactivated and latent varicella-zoster virus in human dorsal root ganglia.

Authors:  O Lungu; P W Annunziato; A Gershon; S M Staugaitis; D Josefson; P LaRussa; S J Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

9.  Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency.

Authors:  O Lungu; C A Panagiotidis; P W Annunziato; A A Gershon; S J Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  Varicella-zoster virus RNA in human trigeminal ganglia.

Authors:  R W Hyman; J R Ecker; R B Tenser
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321

View more
  84 in total

1.  Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Neutralizing anti-gH antibody of Varicella-zoster virus modulates distribution of gH and induces gene regulation, mimicking latency.

Authors:  Kimiyasu Shiraki; Tohru Daikoku; Masaya Takemoto; Yoshihiro Yoshida; Kazuhiro Suzuki; Yasushi Akahori; Toshiomi Okuno; Yoshikazu Kurosawa; Yoshizo Asano
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

Review 3.  Neurovirological methods and their applications.

Authors:  P G E Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

4.  Effect of time delay after necropsy on analysis of simian varicella-zoster virus expression in latently infected ganglia of rhesus macaques.

Authors:  Ravi Mahalingam; Vicki Traina-Dorge; Mary Wellish; Eileen Deharo; Anjani Golive; Ilhem Messaoudi; Don Gilden
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

5.  Apparent expression of varicella-zoster virus proteins in latency resulting from reactivity of murine and rabbit antibodies with human blood group a determinants in sensory neurons.

Authors:  Leigh Zerboni; Raymond A Sobel; Michelle Lai; Richard Triglia; Megan Steain; Allison Abendroth; Ann Arvin
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

6.  The cellular localization pattern of Varicella-Zoster virus ORF29p is influenced by proteasome-mediated degradation.

Authors:  Christina L Stallings; Gregory J Duigou; Anne A Gershon; Michael D Gershon; Saul J Silverstein
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  BAG3, a host cochaperone, facilitates varicella-zoster virus replication.

Authors:  Christos A Kyratsous; Saul J Silverstein
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

8.  Nuclear import of the varicella-zoster virus latency-associated protein ORF63 in primary neurons requires expression of the lytic protein ORF61 and occurs in a proteasome-dependent manner.

Authors:  Matthew S Walters; Christos A Kyratsous; Shilin Wan; Saul Silverstein
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

9.  Identification of phosphorylated residues on varicella-zoster virus immediate-early protein ORF63.

Authors:  Niklaus H Mueller; Matthew S Walters; Roland A Marcus; Laurie L Graf; Jessica Prenni; Don Gilden; Saul J Silverstein; Randall J Cohrs
Journal:  J Gen Virol       Date:  2010-01-20       Impact factor: 3.891

10.  Varicella-zoster virus infection of human neural cells in vivo.

Authors:  Armin Baiker; Klaus Fabel; Antonio Cozzio; Leigh Zerboni; Konstanze Fabel; Marvin Sommer; Nobuko Uchida; Dongping He; Irving Weissman; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.